** Drugmaker Fennec Pharmaceuticals' FENC.O shares down 11.7% at $6.07
** Co posts quarterly net loss of 6 cents per share compared to analysts' estimate of profit of 17 cents per share, according to data compiled by LSEG
** Co also reports fourth-quarter product sales of $7.93 million, missing analysts' estimate of $16.72 million
** Up to last close, FENC has fallen 28.4% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.